Read our latest press releases, hear our most recent media appearances, and see which upcoming events we are attending.
Subscribe to our social channels to ensure you get our updates, news and announcements as and when they happen.
Medicines Discovery Catapult (MDC), a national Life Sciences service dedicated to driving productivity and impact in drug R&D, has strengthened its Executive team with the appointment of a Chief Commercial Officer and its first Managing Director
Science and Health Ministers visited the site, accompanied by the first patient to be scanned using the cutting-edge technology, which will help unlock medical breakthroughs
Recognition of the CF AMR Syndicate’s impact this World AMR Awareness Week (18-24 November 2024)
PACE provides funding and support for innovative, high value, high risk, early phase drug discovery and diagnostic projects
Cross-sector initiative provides funding and support to accelerate new treatments for lung infections in CF
There is no excerpt because this is a protected post.
A partnership between ERS Genomics and Medicines Discovery Catapult will use CRISPR gene editing technology to transform the way medicines are developed
MDC maintains its high impact, nationally strategic role in the UK bioscience sector
Annual Report and Consolidated Financial Statement For the Year Ended 31 March 2024
See how we can help support you with your next drug discovery project.
Speak to us
